{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:24:03Z","timestamp":1792664643852,"version":"4.5.0"},"reference-count":37,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study investigates drug-drug interactions (DDIs) in people with HIV (PWH) receiving antiretroviral therapy (ART) with comorbidities. We focus on pharmacological factors and evaluate DDI notifications from online databases, emphasizing the clinical relevance of pharmacokinetic, pharmacodynamic, and pharmacogenomic variations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted using PubMed, ScienceDirect, Google Scholar, and the Cochrane Library for studies published between January 2019 and September 2024. Newly identified DDI evidence was analyzed by comparing DrugBank, Drugs.com, and the Liverpool HIV databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eleven studies met the inclusion criteria. The findings of these studies showed the critical importance of considering DDIs in PWH with\n                      <jats:italic toggle=\"yes\">tuberculosis<\/jats:italic>\n                      (TB), malaria, and pulmonary hypertension. Severe adverse drug reactions associated with ARTs, including efavirenz, darunavir, nevirapine, and atazanavir-ritonavir, especially when combined with treatments for TB and malaria. Key interactions included reduced drug levels from rifampicin and QT prolongation from artemether-lumefantrine. Pharmacogenomic factors, such as\n                      <jats:italic toggle=\"yes\">CYP2B6<\/jats:italic>\n                      slow metabolism during pregnancy, influenced outcomes. Database discrepancies were noted, especially for riociguat interactions and ritonavir through inhibition of P-gp or OATP1B1 functions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DDIs in PWH receiving ART with comorbidities have highlighted the crucial need for personalized treatment. Incorporating pharmacokinetic, pharmacodynamic, and pharmacogenomic factors is essential for optimizing therapy outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09564624251385831","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:25:14Z","timestamp":1761935114000},"page":"280-296","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Insights from systematic reviews (2019\u20132024) and drug interaction database analysis in people with HIV and comorbidities"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3990-0976","authenticated-orcid":false,"given":"Cherdsak","family":"Boonyong","sequence":"first","affiliation":[{"name":"Rangsit University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phattarapon","family":"Boonsing","sequence":"additional","affiliation":[{"name":"Rangsit University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laphatsanan","family":"Ruangritpassorn","sequence":"additional","affiliation":[{"name":"Rangsit University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phasapon","family":"Thayutichayaton","sequence":"additional","affiliation":[{"name":"Rangsit University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phomin","family":"Rattanamungkun","sequence":"additional","affiliation":[{"name":"Rangsit University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattharika","family":"Chaiboonrueang","sequence":"additional","affiliation":[{"name":"Rangsit University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pannapa","family":"Powthong","sequence":"additional","affiliation":[{"name":"Rangsit University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.22246"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00028-0"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2024.2317954"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae485"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037649"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389200224666230228103922"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1694901"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283389129"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102488"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-022-01001-5"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03384-1"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2018.0190"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2020.04.003"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13050"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25449"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.24543"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04466-w"},{"key":"e_1_3_4_21_2","first-page":"605","article-title":"Evaluation of cardiotoxicity and other adverse effects associated with concomitant administration of artemether\/lumefantrine and atazanavir\/ritonavir-based antiretroviral regimen in patients living with HIV","volume":"30","author":"Usman SO","year":"2022","unstructured":"Usman SO, Oreagba IA, Busari A, et al. Evaluation of cardiotoxicity and other adverse effects associated with concomitant administration of artemether\/lumefantrine and atazanavir\/ritonavir-based antiretroviral regimen in patients living with HIV. SPJ 2022; 30: 605\u2013612.","journal-title":"SPJ"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00136-22"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa470"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2044"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045894019848644"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac585"},{"key":"e_1_3_4_27_2","first-page":"0043023","article-title":"Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard-versus high-dose rifampicin","volume":"67","author":"Kengo A","year":"2023","unstructured":"Kengo A, Nabisere R, Gausi K, et al. Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard-versus high-dose rifampicin. Antimicrob Agents Chemother 2023; 67: 0043023.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1026"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15309"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz557"},{"key":"e_1_3_4_31_2","first-page":"282","article-title":"Quality of care for people with HIV infection and AIDS receiving antiretroviral therapy in Bamrasnaradura Infectious Diseases Institute","volume":"44","author":"Ardsorn C","year":"2018","unstructured":"Ardsorn C, Namjuntra R, Kimsungnoen N. Quality of care for people with HIV infection and AIDS receiving antiretroviral therapy in Bamrasnaradura Infectious Diseases Institute. Disease Control Journal 2018; 44: 282\u2013292.","journal-title":"Disease Control Journal"},{"key":"e_1_3_4_32_2","first-page":"66","article-title":"Prevalence of low birthweight infants in HIV-infected women delivered in Rajavithi Hospital","volume":"94","author":"Asavapiriyanont S","year":"2011","unstructured":"Asavapiriyanont S, Kasiwat S. Prevalence of low birthweight infants in HIV-infected women delivered in Rajavithi Hospital. J Med Assoc Thail 2011; 94 Suppl 2: 66\u201370.","journal-title":"J Med Assoc Thail"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.15586\/jptcp.v27i3.686"},{"key":"e_1_3_4_34_2","first-page":"9","article-title":"Effects of radiation therapy on immunological and virological status in HIV-infected cancer patients in Thailand: a multicenter prospective study","volume":"99","author":"Siraprapasiri P","year":"2016","unstructured":"Siraprapasiri P, Tharavichitkul E, Suntornpong N, et al. Effects of radiation therapy on immunological and virological status in HIV-infected cancer patients in Thailand: a multicenter prospective study. J Med Assoc Thail 2016; 99: 9\u201316.","journal-title":"J Med Assoc Thail"},{"key":"e_1_3_4_35_2","first-page":"14","article-title":"Effects of cognitive and behavioral program on drug adherence, CD4 and AIDS knowledge in late adolescent and early adult HIV\/AIDS patients","volume":"67","author":"Sriondee R","year":"2015","unstructured":"Sriondee R, Nateetanasombat K, Namjuntra R, et al. Effects of cognitive and behavioral program on drug adherence, CD4 and AIDS knowledge in late adolescent and early adult HIV\/AIDS patients. Siriraj Medical Journal 2015; 67: 14\u201319.","journal-title":"Siriraj Medical Journal"},{"key":"e_1_3_4_36_2","volume-title":"Guidelines for the use of antiretroviral agents in adults and adolescents with HIV","author":"U.S. Department of Health and Human Services (HHS)","year":"2024","unstructured":"U.S. Department of Health and Human Services (HHS). Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. HHS, 2024."},{"key":"e_1_3_4_37_2","volume-title":"Consolidated Guidelines on HIV Treatment, (2nd ed)","author":"World Health Organization (WHO)","year":"2021","unstructured":"World Health Organization (WHO). Consolidated Guidelines on HIV Treatment, (2nd ed). WHO, 2021."},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2024.2305130"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624251385831","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09564624251385831","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624251385831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:47:12Z","timestamp":1777675632000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09564624251385831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/09564624251385831"],"URL":"https:\/\/doi.org\/10.1177\/09564624251385831","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]}}}